EMBC vs HQY: fair value comparison
Embecta Corp. and HealthEquity, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, HQY currently sits closer to the top of our ranking by discount to fair value. HQY carries the stronger quality grade.
| EMBC | HQY | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $6.27 | $92.03 |
| 12-month range | $2.90–$14.64 | $73.21–$106.79 |
| Rank by discount to fair value | #11 of 108 Healthcare | #10 of 108 Healthcare |
| Quality grade | B | A |
| Leverage | Low | Low |
| Margin trend | Contracting | Expanding |
| Revenue growth | Declining | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Mixed |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: EMBC fair value analysis · HQY fair value analysis